Target intelligence / Profile preview

Protocadherin-15 (PCDH15)

Target
PCDH15
Molecular classification
Cadherin superfamily, Protocadherin subgroup, Integral membrane protein, Cell-adhesion molecule
01

Overview

Protocadherin-15 is a transmembrane cell-adhesion protein encoded by the *PCDH15* gene and is essential for normal function in the cochlea and retina. Protocadherin-15 is a member of the cadherin superfamily of calcium-dependent cell-adhesion proteins. It consists of 11 extracellular cadherin repeats, a transmembrane domain, and a unique cytoplasmic domain. In the inner ear, protocadherin-15 and cadherin-23 form filamentous tip links that convey forces to mechanotransduction channels, allowing sound sensation. Its structure allows for flexibility and mechanical gating critical for auditory function. Protocadherin-15 is also essential in retinal cell maintenance. Mutations in the *PCDH15* gene are linked to autosomal recessive disorders, including Usher syndrome type 1F, characterized by deafness, balance problems, and progressive blindness. Variations in the gene can produce a spectrum of phenotypes, from full syndromic presentation to isolated hearing loss. There is currently no evidence of its direct druggability or modulation by approved therapeutics.

Other names
USH1FCDHR15cadherin-related family member 15DFNB23protocadherin-15
02

Mechanism of action

Not applicable; no drugs are known to target this molecule directly

03

Biological functions

Calcium-dependent cell–cell adhesionFormation of tip links in inner ear hair cells (critical for mechanotransduction of sound)Involved in retinal photoreceptor maintenance
04

Disease associations

Hearing loss (congenital sensorineural deficit)Usher syndrome type 1F (profound deafness, vestibular dysfunction, retinitis pigmentosa)Non-syndromic hearing loss (certain variants)
05

Safety considerations

Therapeutic challenges include the complexity of gene therapy for sensory organ proteins and potential off-target effects in developing treatments for Usher syndrome
06

Biomarkers

Mutational analysis of *PCDH15* for diagnosis of Usher syndrome type 1F and related hearing loss

Beyond the preview

Go deeper on Protocadherin-15 (PCDH15).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protocadherin-15 (PCDH15).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call